NCT00975481 - A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions

Alzheimer's DiseaseHuntington's Disease

Interventions

DRUG

dimebon

Oral tablet; 20 mg dimebon, single dose

DRUG

dimebon

Oral tablet; 40 mg dimebon, single dose

DRUG

dimebon

Oral tablet; 60 mg dimebon, single dose

DRUG

placebo

Oral tablet or capsule; placebo, single dose

DRUG

alprazolam

Oral capsule; 1 mg alprazolam, single dose

DRUG

alprazolam

Oral capsule; 3 mg alprazolam, single dose